AVITA Medical Inc（RCEL）價格預測

$10.070

-0.030 (-0.30%)收盤時

價格預測

1-Day Price Prediction

+1.07%

1-Week Prediction

-0.35%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

RCEL 相似圖表分析預測

Alphio's RCEL stock price prediction model matches the current AVITA Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.18 (+1.07%). The 1-week path is $10.03 (-0.35%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 AVITA Medical Inc 股票嗎？

AVITA Medical Inc (RCEL) is a good buy right now, trading at $10.35 with a strong recent performance of 198.27% year-to-date. The RSI is at 73.4, indicating strong momentum, and analysts have raised their price targets to a range of $11 to $14, suggesting significant upside potential. The main risk is the company's ongoing net losses, which were $7.66 million in Q2 2026, but the trend shows improvement in revenue and cost management.

RCEL 股價於 Tuesday 收在 $10.07，此前下跌 -0.30%

AVITA Medical Inc (RCEL) last closed at $10.07, losing -0.30%. These facts feed the 1-day and 1-week RCEL price prediction above.

預測驅動因素

AVITA Medical Inc（RCEL）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 RCEL 最接近的股票，依相似度排序。

GMED

95.64%

-51.00%

BTSG

95.43%

-52.00%

HRB

95.37%

+1.97%

FERG

94.83%

+3.89%

COGT

94.73%

-12.85%

RCEL 季節性分析

Historically the probability of a positive September return for RCEL is 2.38%. February offers the highest probability of a positive month at 67.24%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…